Arkolith/Insider Trading/PAHC/Form 4

Bendheim Jack

President and CEO, Director, 10% OwnerPHIBRO ANIMAL HEALTH CORP (PAHC) · full profile →Form 4 · filed Jan 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$50K
Net Open-Market Flow
-$50K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2026Conversion(C)30K—$045K
Jan 23, 2026Sell(S)1K$40.55$50K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2026Conversion(C)30K—$019.9M

Transaction Codes

C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-006986) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML